Radicava Drug Insight Report, 2019: Drug Overview, Mechanism of Action, Clinical Trials, Regulatory Milestones, Deals, Partnerships, and Sales Forecasting to 2021 - ResearchAndMarkets.com

DUBLIN--()--The "Radicava - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.

Radicava - Drug Insight, 2019 report provides comprehensive information of the drug, Radicava.

It includes drugs overview, Radicava mechanism of action, clinical trials, regulatory milestones, deals & Radicava's partnerships. It further provides Radicava`s patents (US & EU) and its API manufacturers details in the United States, Europe, China and India.

It also features the historical and forecasted Radicava sales till 2021. The report also throws light on Radicava market competition and emerging therapies in the same space as Radicava. Radicava SWOT analysis is also featured.

Scope of the Report

  • A comprehensive Radicava overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
  • Radicava Patent information in United States (US) and Europe (EU) has been highlighted
  • Radicava API manufacturers in United States, Europe, China and India
  • The report contains historical and forecasted Radicava sales till 2021
  • Comprehensive coverage of the emerging therapies (Phase III) in the space where Radicava operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
  • The report also features the Radicava SWOT analysis

Reasons to Buy

  • Establish a comprehensive understanding of the drug, Radicava
  • Access to Radicava API manufacturers details to devise API procurement strategy for generic development
  • Plan developmental timelines around Radicava patents for the major markets- US and EU
  • Understand current and future Radicava`s growth through its historical and forecasted sales
  • Identify and understand the current in-market competitors for Radicava
  • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
  • Identify and plan ahead for prospective emerging players and their products operating in the same space as Radicava
  • Identify opportunities in the same area as with Radicava SWOT analysis

Key Topics Covered

1. Report Introduction

2. Radicava - Overview

  • Radicava Product Description
  • Radicava Route of Synthesis
  • Radicava Mechanism of Action
  • Radicava Pharmacology
  • Radicava Pharmacodynamics
  • Radicava Pharmacokinetics
  • Radicava Adverse Reactions
  • Radicava Clinical Trials
  • Radicava Regulatory Milestones
  • Radicava Development Activities

3. Global API Manufacturers

  • United States
  • Europe
  • China
  • India

4. Product Details

  • United States
  • Europe

5. Radicava Global Sales Assessment

  • Radicava Sales Global(Historical)
  • Radicava Sales Global(Forecasted)

6. Radicava Patent Details

7. Radicava Market Competition

8. Radicava Emerging Therapies

8.1. Drug name: Company name

  • Product Description
  • Research & Development
  • Product Development Activities

9. Radicava SWOT Analysis

List of Tables

Table 1: Radicava, Description

Table 2: API Manufacturers Region wise

Table 3: API Manufacturers for United States

Table 4: API Manufacturers for Europe

Table 5: API Manufacturers for China

Table 6: API Manufacturers for India

Table 7: Radicava Product Details, United States

Table 8: Radicava Product Details, Europe

Table 9: Radicava, Historical Global Sales till 2017 (in million USD)

Table 10: Radicava, Forecasted Global Sales from 2019-2021 (in million USD)

Table 11: Patent Details: Radicava

Table 12: Radicava Major Competitors

Table 13: Emerging Therapies

List of Figures

Figure 1: Radicava

Figure 2: Radicava, Historical Global Sales till 2017 (in million USD)

Figure 3: Radicava, Forecasted Global Sales from 2019-2021 (in million USD)

Figure 4: Patent Details: Radicava

Figure 5: API Manufacturers Region wise

For more information about this report visit https://www.researchandmarkets.com/r/bnm0z4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900